CClinicalTrials.gg
CompletedNCT05866965Updated May 19, 2023

Effect of Platelet-rich Fibrin on Soft Tissue, Periodontal Pocket Healing and Alveolar Bone Height After Third Molar Surgery

An interventional study of PRF and standard third molar surgical removal in Platelet-rich Fibrin, sponsored by Lam Cu Phong. Completed at 1 site in Vietnam. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-05-19.

Sponsored by Lam Cu Phong · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 3 years 4 months after the study started (first participant enrolled Dec 2019, registered Apr 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

A Randomized, controlled clinical trial and split-mouth design was performed to assess and compare the effect of platelet-rich fibrin (PRF) on soft tissue healing, periodontal pocket depth and alveolar bone height distal to second molar of the study and control groups after third molar surgical removal.

Sample include of participants who had indication of impacted lower third molars extraction on both sides with symmetrically orientation and same difficult index. All participants had same extraction protocol on both side at Department of Oral surgery, Faculty of Odonto-stomatology, University of Medicine and Pharmacy, Ho Chi Minh City.

Soft tissue healing, periodontal pocket depth and distal bone height were evaluation by an independent investigator.

02

Conditions studied

  • Platelet-rich Fibrin

Browse trials for

03

In context

Periodontal Pocket

126 studies on the registry are indexed under Periodontal Pocket; 36 are open to participants now.

This study's enrollment of 26 is below the median of 30 across 109 interventional studies indexed under Periodontal Pocket.

Browse Periodontal Pocket studies →

Lead sponsor

This is the only study on the registry with Lam Cu Phong as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patient over 18 years old.
  • Good general health.
  • Bilateral lower third molars equivalent in inclination and Pell and Gregory's impaction classification (classification II, III and B, C). The assessment of equivalence between two mandibular third molars was determined on the panoramic radiograph.
  • The difference of third molar inclination on both sides not greater than 15 degrees.
  • The patient consented to participate in the study after hearing clearly the explanation of purposes and requirements of the study.

Exclusion criteria

Exclusion Criteria:

  • Patients with any systemic disease contraindicated for surgery.
  • Presence of acute inflammation or infection at third molar areas.
  • Patients refused to participate in the study, did not comply with treatment or did not come to the follow-up examination as required.
  • The difference in surgical time between the two groups was more than 10 minutes.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
26 participants (actual)

Study arms

  • Active comparator
    control

    standard third molar surgery following surgical protocol of Department of Oral Surgery, University of Medicine and Pharmacy

    Other: standard third molar surgical removal

  • Experimental
    PRF

    PRF was applied in third molar socket after removal following surgical protocol of Department of Oral Surgery, University of Medicine and Pharmacy

    Other: PRF

Interventions

  • OtherPRF

    centrifuge patient's blood to collect 1 block of yellowish condensed fibrin, which is platelet-rich fibrin

  • Otherstandard third molar surgical removal

    standard third molar surgery following surgical protocol of Department of Oral Surgery, University of Medicine and Pharmacy

06

What researchers measure

Primary outcomes

  1. periodontal pocket depth

    periodontal pocket depth at distal buccal and distal lingual side of second molar

    Time frame: 1rst postoperative month

  2. periodontal pocket depth

    periodontal pocket depth at distal buccal and distal lingual side of second molar

    Time frame: 3rst postoperative month

  3. periodontal pocket depth

    periodontal pocket depth at distal buccal and distal lingual side of second molar

    Time frame: 6rst postoperative month

  4. distal bone resorption

    resorption of alveolar bone height distal to second molar

    Time frame: 3rd postoperative month

  5. distal bone resorption

    resorption of alveolar bone height distal to second molar

    Time frame: 6th postoperative month

Secondary outcomes

  1. soft tissue healing index

    soft tissue healing around third molar socket

    Time frame: 3rd postoperative day

  2. soft tissue healing index

    soft tissue healing around third molar socket

    Time frame: 7th postoperative day

07

Study locations

1 site
  • University of Medicine and Pharmacy
    Ho Chi Minh City, 700000, Vietnam
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 19, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05866965
Lead sponsor
Lam Cu Phong
Responsible party
Lam Cu Phong (Lecturer, University of Medicine and Pharmacy at Ho Chi Minh City) — Sponsor-investigator
First posted
May 19, 2023
Start date
Dec 1, 2019
Primary completion
Jun 1, 2021
Completion
Dec 1, 2021
Last update
May 19, 2023

Study contacts

Phong Cu Lam, Master
principal investigator · University of Medicine and Pharmacy, Ho Chi Minh city

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion